Last edition
News about "Dapagliflozin Tablets"
Inventia Healthcare Launches Generic Dapagliflozin in US After FDA Approval
Inventia Healthcare has secured FDA approval for dapagliflozin tablets and begun Day-One commercialisation, expanding access to affordable diabetes and heart failure treatment in the US.
Dapagliflozin Tablets | 09/04/2026 | By News Bureau | 111
Lupin Secures US FDA Approval for Dapagliflozin Tablets in US
Lupin secures US FDA approval for Dapagliflozin Tablets 5 mg and 10 mg in the US, bioequivalent to Farxiga.
Dapagliflozin Tablets | 08/04/2026 | By News Bureau
Alembic Pharmaceuticals Gains USFDA Approval for Dapagliflozin Tablets ANDA
Alembic Pharmaceuticals receives USFDA approval for Dapagliflozin Tablets ANDA, gaining eligibility for 180-day shared generic drug exclusivity and strengthening its diabetes portfolio.
Dapagliflozin Tablets | 07/04/2026 | By News Bureau
Zydus Gets USFDA Tentative Nod for Dapagliflozin Tablets
Zydus has received tentative approval from the US Food and Drug Administration (USFDA) for dapagliflozin tablets in 5 mg and 10 mg strengths, paving the way for the company’s entry into the US market subject to final approval.
Dapagliflozin Tablets | 06/02/2026 | By News Bureau | 122
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy